- Home
- PBT vs AUTL Comparison
PBT vs AUTL Comparison
Compare PBT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- AUTL
- Stock Information
- Founded
- PBT 1980
- AUTL 2014
- Country
- PBT United States
- AUTL United Kingdom
- Employees
- PBT N/A
- AUTL N/A
- Industry
- PBT Oil & Gas Production
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBT Energy
- AUTL Health Care
- Exchange
- PBT Nasdaq
- AUTL Nasdaq
- Market Cap
- PBT 558.4M
- AUTL 590.8M
- IPO Year
- PBT N/A
- AUTL 2018
- Fundamental
- Price
- PBT $11.10
- AUTL $2.17
- Analyst Decision
- PBT
- AUTL Strong Buy
- Analyst Count
- PBT 0
- AUTL 3
- Target Price
- PBT N/A
- AUTL $10.20
- AVG Volume (30 Days)
- PBT 116.9K
- AUTL 1.1M
- Earning Date
- PBT 01-01-0001
- AUTL 03-13-2025
- Dividend Yield
- PBT 4.81%
- AUTL N/A
- EPS Growth
- PBT 25.21
- AUTL N/A
- EPS
- PBT 0.78
- AUTL N/A
- Revenue
- PBT $37,735,284.00
- AUTL $10,091,000.00
- Revenue This Year
- PBT N/A
- AUTL $851.83
- Revenue Next Year
- PBT N/A
- AUTL $224.65
- P/E Ratio
- PBT $14.14
- AUTL N/A
- Revenue Growth
- PBT 25.46
- AUTL 82.71
- 52 Week Low
- PBT $10.14
- AUTL $2.07
- 52 Week High
- PBT $14.58
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- PBT 39.41
- AUTL 41.81
- Support Level
- PBT $10.95
- AUTL $2.11
- Resistance Level
- PBT $11.41
- AUTL $2.26
- Average True Range (ATR)
- PBT 0.42
- AUTL 0.12
- MACD
- PBT -0.06
- AUTL 0.01
- Stochastic Oscillator
- PBT 15.05
- AUTL 27.78
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.